| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 01/21/2009 | EP2016034A2 Mono-nitration of aromatic compounds |
| 01/21/2009 | CN101348471A Process for the preparation of 4- (3'chloro-4'-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline |
| 01/21/2009 | CN101348448A Preparation of ion liquid having B acid center and L acid center |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/20/2009 | US7479559 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation |
| 01/20/2009 | US7479493 e.g. [4-(3,4-Dichloro-phenoxy)-3-methylaminomethyl-phenyl]-(4-isopropyl-piperazin-1-yl)-methanone; histamine H3 receptor and/or serotonin transporter modulator; antidepressant; cognitive disorders, sleep disorders, psychiatric disorders, drug abuse, sexual dysfunction |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2465738C Unsaturated 1-amino-alkylcyclohexane nmda, 5ht3 and neuronal nicotinic receptor antagonists |
| 01/20/2009 | CA2396678C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2174061C 7-substituted quinone methides as inhibitors for unsaturated monomers |
| 01/15/2009 | WO2009008492A1 Process for producing macrolide compound and intermediate therefor |
| 01/15/2009 | WO2008101914A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase |
| 01/15/2009 | US20090018143 Thio-substituted arylmethanesulfinyl derivatives |
| 01/15/2009 | US20090018116 Therapeutic Compounds |
| 01/15/2009 | US20090018103 Diaminoalkane Aspartic Protease Inhibitors |
| 01/15/2009 | US20090018058 Vitamin D Receptor Modulators |
| 01/15/2009 | CA2692644A1 Method for producing macrolide compound and production intermediate therof |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP2013192A1 4-amino-2,6-dimethylphenol compound, process for its preparation and pharmaceutical composition comprising the same |
| 01/14/2009 | EP1395567B1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 01/14/2009 | EP1345899B1 N-substituted amides as NK1 receptor antagonists |
| 01/14/2009 | EP1331221B1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 01/14/2009 | CN101343259A Method for synthesis of N-phenyl pyrrolidine with particle type solid ultra-corrosive acid catalysis |
| 01/14/2009 | CN101343258A Method for synthesis of pyrrolidine with particle type solid ultra-corrosive acid catalysis |
| 01/14/2009 | CN100451014C Process for making chiral 1,4-disubstituted piperazines |
| 01/14/2009 | CN100450994C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/13/2009 | US7476690 Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 01/13/2009 | US7476672 Acetylenic compounds useful in treating inflammatory disorders |
| 01/13/2009 | CA2346506C Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 01/08/2009 | WO2009006267A2 N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles |
| 01/08/2009 | WO2009005069A1 Method of deuteration using ruthenium catalyst |
| 01/08/2009 | WO2009004379A1 Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates |
| 01/08/2009 | WO2009003589A1 A process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates |
| 01/08/2009 | WO2008134474A3 Compositions and methods including cell death inducers and procaspase activation |
| 01/08/2009 | WO2008110586A3 New process for the preparation of levocetirizine and intermediates thereof |
| 01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/08/2009 | US20090012300 Process for the Preparation of an (Hetero) Arylamine |
| 01/08/2009 | US20090012099 Novel Compounds |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | CA2692222A1 A process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates |
| 01/08/2009 | CA2691615A1 Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates |
| 01/07/2009 | EP2010479A1 11 beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/07/2009 | EP1858867B1 Trifluoromethylbenzamide derivatives and therapeutic uses thereof |
| 01/07/2009 | EP1357909B1 Il-8 receptor antagonists |
| 01/07/2009 | EP1333024B1 Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 01/07/2009 | EP1292300B1 Combinations od dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment fo diabete mellitus |
| 01/07/2009 | CN101341141A Photochromic indeno-fused naphthopyrans |
| 01/07/2009 | CN101341125A New phenanthridine derivatives as bradykinin antagonists |
| 01/07/2009 | CN101337949A Method for synthesizing beta-amido carboxylic acid ester |
| 01/07/2009 | CN100448849C Process for preparing 4-acyl substituted-2-methylpiperazines |
| 01/07/2009 | CN100448844C Inhibitors of histone deacetylase |
| 01/06/2009 | US7473779 e.g. 2-amino-N-(4-{[amino(2-thienyl)methylidene]amino}phenethyl)-5-methoxybenzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 01/06/2009 | US7473692 Sulfonamide derivatives as D3-receptor ligands |
| 01/06/2009 | US7473690 Tetralin and indane derivatives and uses thereof |
| 01/06/2009 | CA2421008C Substituted heterocyclic compounds for treating multidrug resistance |
| 01/01/2009 | US20090005562 N-(2,4,6-triisopropylphenylsulfonyl)-3-amidino(or guanidino)phenyl-alanine 4-ethoxycarbonylpiperazide; urokinase inhibitors; reacting a 3-cyanophenylalanine with a quaternary ammonium hydroxide and reacting the product with a phenylsulfonyl halide; industrial scale; simplification; cost efficiency |
| 01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
| 12/31/2008 | WO2009001127A1 Cyanocyclopropylcarboxamides as cathepsin inhibitors |
| 12/31/2008 | WO2008129288A3 Disulfonamides useful in the treatment of inflammation |
| 12/31/2008 | EP2007740A1 Process for preparing linezolid |
| 12/31/2008 | EP2007720A1 Benzamide derivatives as inhibitors of histone deacetylase |
| 12/31/2008 | EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound |
| 12/31/2008 | CN101333199A Method for synthesizing 4-(2-(N,N-dimethylamino)ethyl)morpholine |
| 12/31/2008 | CN100447126C Omega substituted naphthyloxy-amino alkane den-ivative used as anti-hyperglycaemia agent and its preparation therefor |
| 12/31/2008 | CN100446749C hair cosmetics, aminocarboxylic acid amide and its producing process |
| 12/30/2008 | US7471502 Ionic liquids, electrolyte salts for electrical storage devices, liquid electrolytes for electrical storage devices, electrical double-layer capacitors, and secondary batteries |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | CA2351703C Novel 4-dedimethylaminotetracycline derivatives |
| 12/25/2008 | US20080318951 Dual-acting benzoimidazole antihypertensive agents |
| 12/25/2008 | US20080318942 Fredericamycin Derivatives |
| 12/24/2008 | WO2008157240A1 Substituted piperazines |
| 12/24/2008 | WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof |
| 12/24/2008 | WO2008133937A3 Compositions of tolperisone |
| 12/24/2008 | WO2008124524A3 Aryl sulfonamide compounds as modulators of the cck2 receptor |
| 12/24/2008 | WO2007117653A3 Cdk9-pi3k-akt inhibitors for cancer treatment |
| 12/24/2008 | EP2004619A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases |
| 12/24/2008 | EP2004618A1 Telomerase inhibitors |
| 12/24/2008 | EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2008 | EP2004596A2 Compositions useful as inhibitors of voltage-gated sodium channels |
| 12/24/2008 | EP1620102B1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
| 12/24/2008 | EP1461306B1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 12/24/2008 | CN101331124A Novel vanilloid receptor ligands and their use for producing medicaments |
| 12/24/2008 | CN101331122A Salts of modulators of PPAR and methods of treating metabolic disorders |
| 12/24/2008 | CN101331121A Racemic separation of 2,6-trans-dimethymorpholine |
| 12/24/2008 | CN101328157A Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 12/24/2008 | CN100445276C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 12/24/2008 | CN100445275C Repaglinide synthesis process |
| 12/24/2008 | CN100445266C MCH antagonists and their use in treatment of obesity |
| 12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
| 12/24/2008 | CA2690379A1 Substituted piperazines |
| 12/23/2008 | US7468393 Diarylsulfones as 5-HT2A antagonists |
| 12/23/2008 | US7468383 Proteasome inhibitors and methods of using the same |
| 12/23/2008 | CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/23/2008 | CA2212326C O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same |
| 12/18/2008 | WO2008154642A2 Antibacterial agents |
| 12/18/2008 | WO2008154484A1 Ire-1a inhibitors |
| 12/18/2008 | WO2008154091A1 Thiourea derivatives |